Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone.

Ítems similars

• Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet.
  per: Koshida, R, et al.
  Publicat: (1989)
• Synergistic inhibition of human immunodeficiency virus isolates (including 3'-azido-3'-deoxythymidine-resistant isolates) by foscarnet in combination with 2',3'-dideoxyinosine or 2',3'-dideoxycytidine.
  per: Palmer, S, et al.
  Publicat: (1996)
• Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro.
  per: Chong, K T, et al.
  Publicat: (1994)
• Mutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidine.
  per: Remington, K M, et al.
  Publicat: (1991)
• Dipyridamole potentiates the inhibition by 3'-azido-3'-deoxythymidine and other dideoxynucleosides of human immunodeficiency virus replication in monocyte-macrophages.
  per: Szebeni, J, et al.
  Publicat: (1989)